Delivery Order SPE2DB22D3501-SPE2DB24FVJ72
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Primaquine 26.3 mg tablets. The contract, valued at $20,780.83, is a Firm Fixed Price delivery order with a completion date of September 13, 2024. The contract is not designated as a set-aside. As one of the largest pharmaceutical distributors in the United States, AmerisourceBergen has extensive Indefinite Delivery Contracts (IDCs)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,599.35, is for the delivery of Primaquine 26.3 mg tablets over a period ending on March 28, 2025. This is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,642.00, is a Firm Fixed Price Delivery Order for the supply of Primaquine 26.3MG 100S, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,932.49, is a firm fixed-price delivery order for 4,563,868,019 units of the drug Primaquine 26.3 mg Tablet 100s. The contract has an ultimate completion date of March 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a ceiling value of $11,975.23 for the supply of Primaquine 26.3 mg tablets. The contract is not set aside and is a firm fixed-price type. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- The Defense Logistics Agency awarded a $2,018.72 delivery order to AmerisourceBergen Drug Corp for Primaquine 26.3 mg tablets (100-count) with a completion date of September 29, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and extending through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $95,047.08 contract is a firm fixed-price delivery order for the supply of Primaquine 26.3mg tablets, a medication used to prevent malaria. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,911.20 Firm Fixed Price Delivery Order contract is for the supply of PRIMAQUINE 26.3MG 100S, a pharmaceutical product, with a performance period through April 2, 2025. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to serve as a prime vendor for pharmaceutical products and medical supplies. The contract, valued at $1,047.01, is a delivery order that runs through November 2020. It is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and lasting through November 2026. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,633.04 firm fixed-price delivery order for Primaquine 26.3 mg tablets (100-count units) with an ultimate completion date of June 5, 2025. This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVJ72Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The award, valued at $1,648.66, is for the delivery of 4564360935 - Primaquine 26.3 mg tablets in quantities of 100 per bottle. The contract has an ultimate completion date of April 23, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract award was made on a full and open competition basis without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 4/22/24 |